These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 986183)

  • 1. Interaction of short chain and long chain fatty acid phosphoglycerides and bile salts with prothrombin.
    Bajwa SS; Hanahan DJ
    Biochim Biophys Acta; 1976 Aug; 444(1):118-30. PubMed ID: 986183
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interactions of the components of the prothrombinase complex.
    Subbaiah PV; Bajwa SS; Smith CM; Hanahan DJ
    Biochim Biophys Acta; 1976 Aug; 444(1):131-46. PubMed ID: 986184
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Determinants of the formation and activity of factor V-phospholipid complexes. I. Influence of phospholipid structure.
    Kandall CL; Shohet SB; Akinbami TK; Colman RW
    Thromb Diath Haemorrh; 1975 Sep; 34(1):256-70. PubMed ID: 1237944
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of blood clotting factor V in the conversion of prothrombin and a decarboxy prothrombin into thrombin.
    Vermeer C; Govers-Riemslag JW; Soute BA; Lindhout MJ; Kop J; Hemker HC
    Biochim Biophys Acta; 1978 Feb; 538(3):521-33. PubMed ID: 564211
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of phospholipids and factor Va in the prothrombinase complex.
    Rosing J; Tans G; Govers-Riemslag JW; Zwaal RF; Hemker HC
    J Biol Chem; 1980 Jan; 255(1):274-83. PubMed ID: 7350159
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factor Va-factor Xa interaction. Effects of phospholipid vesicles of varying composition.
    Lindhout T; Govers-Riemslag JW; van de Waart P; Hemker HC; Rosing J
    Biochemistry; 1982 Oct; 21(22):5494-502. PubMed ID: 7171570
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Studies of the conversion mechanism of prothrombin into thrombin.
    Okabe H
    Tohoku J Exp Med; 1974 Nov; 114(3):215-25. PubMed ID: 4456684
    [No Abstract]   [Full Text] [Related]  

  • 8. The effect of phospholipids, calcium ions and protein S on rate constants of human factor Va inactivation by activated human protein C.
    Bakker HM; Tans G; Janssen-Claessen T; Thomassen MC; Hemker HC; Griffin JH; Rosing J
    Eur J Biochem; 1992 Aug; 208(1):171-8. PubMed ID: 1387359
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of bovine factor V by an activator purified from the venom of Naja naja oxiana.
    Gerads I; Tans G; Yukelson LYa ; Zwaal RF; Rosing J
    Toxicon; 1992 Sep; 30(9):1065-79. PubMed ID: 1440644
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of bovine prothrombin fragment 1 and fragment 1.2 on prothrombin activation.
    Govers-Riemslag JW; Speijer H; Zwaal RF; Rosing J
    Thromb Res; 1985 May; 38(4):375-88. PubMed ID: 3925588
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Kinetic studies of prothrombin activation: effect of factor Va and phospholipids on the formation of the enzyme-substrate complex.
    van Rijn JL; Govers-Riemslag JW; Zwaal RF; Rosing J
    Biochemistry; 1984 Sep; 23(20):4557-64. PubMed ID: 6498156
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A polypeptide region of bovine prothrombin specific for binding to phospholipids.
    Gitel SN; Owen WG; Esmon CT; Jackson CM
    Proc Natl Acad Sci U S A; 1973 May; 70(5):1344-8. PubMed ID: 4514304
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interaction of prothrombin with factor Va-phospholipid complexes.
    van de Waart P; Hemker HC; Lindhout T
    Biochemistry; 1984 Jun; 23(12):2838-42. PubMed ID: 6466619
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interaction of bovine blood clotting factor Va and its subunits with phospholipid vesicles.
    van de Waart P; Bruls H; Hemker HC; Lindhout T
    Biochemistry; 1983 May; 22(10):2427-32. PubMed ID: 6860639
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of bovine prothrombin as monitored by the clotting assay.
    Ong TC; Sothy SP
    Biol Chem Hoppe Seyler; 1990 Jan; 371(1):63-8. PubMed ID: 2322420
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prothrombin activation on phospholipid membranes with positive electrostatic potential.
    Rosing J; Speijer H; Zwaal RF
    Biochemistry; 1988 Jan; 27(1):8-11. PubMed ID: 3162382
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kinetics of the activation of human prothrombin by human coagulation factor Xa. Initial rate studies in the presence of Ca2+ and phospholipid.
    Kosow DP; Orthner CL
    J Biol Chem; 1979 Oct; 254(19):9448-52. PubMed ID: 489543
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prothrombin fragments. Ca2+ binding and activation kinetics.
    Bajaj SP; Butkowski RJ; Mann KG
    J Biol Chem; 1975 Mar; 250(6):2150-6. PubMed ID: 1117001
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The functional significance of vitamin K action. Difference in phospholipid binding between normal and abnormal prothrombin.
    Esmon CT; Suttie JW; Jackson CM
    J Biol Chem; 1975 Jun; 250(11):4095-9. PubMed ID: 1126944
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Determinants of the formation and activity of factor V-phospholipid complexes. II. Molecular properties of the complexes.
    Kandall CL; Shohet SB; Akinbami TK; Colman RW
    Thromb Diath Haemorrh; 1975 Sep; 34(1):271-84. PubMed ID: 1188712
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.